Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surni Group is an India-based healthcare manufacturing group focused on nephrology and infection control products. The group traces its origins to Surni Pharmaceuticals, founded in 1994 in Vadodara, Gujarat, and later expanded with Surni Labs in 2011. Its commercial portfolio includes haemodialysis concentrates, dry citrate haemodialysis concentrates, haemodialysis bicarbonate cartridges and bags, and a range of disinfectants used in dialysis and hospital settings. The company describes itself as a leading manufacturer of renal products and exports its products globally. Surni operates regulated manufacturing aligned with CDSCO-India, ISO 9001, ISO 13485, and EU MDR requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surni Group.